Searching News Database: Dendreon
HSMN NewsFeed - 11 Aug 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
HSMN NewsFeed - 27 Mar 2014
Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton
Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton
HSMN NewsFeed - 10 Feb 2014
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
HSMN NewsFeed - 16 Aug 2012
Threshold Pharmaceuticals Appoints Laura G. Hansen, Ph.D., Senior Director, Corporate Communications
Threshold Pharmaceuticals Appoints Laura G. Hansen, Ph.D., Senior Director, Corporate Communications
HSMN NewsFeed - 9 Jul 2012
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
HSMN NewsFeed - 27 Mar 2012
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
HSMN NewsFeed - 14 Nov 2011
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 22 Jul 2010
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
HSMN NewsFeed - 14 Jul 2010
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
HSMN NewsFeed - 19 May 2010
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
HSMN NewsFeed - 15 Apr 2010
Dendreon Appoints Richard Ranieri as Senior Vice President of Human Resources
Dendreon Appoints Richard Ranieri as Senior Vice President of Human Resources
HSMN NewsFeed - 13 Aug 2008
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
HSMN NewsFeed - 13 Mar 2008
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
HSMN NewsFeed - 12 Mar 2008
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
HSMN NewsFeed - 14 Feb 2008
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
HSMN NewsFeed - 20 Sep 2007
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
HSMN NewsFeed - 9 May 2007
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
Dendreon Receives Complete Response Letter From FDA for Provenge(R) Biologics License Application
HSMN NewsFeed - 6 Nov 2006
ARCA Discovery Names Richard B. Brewer President and Chief Executive Officer
ARCA Discovery Names Richard B. Brewer President and Chief Executive Officer
HSMN NewsFeed - 27 Oct 2006
Dendreon Presents New Data Correlating Potency of PROVENGE to Survival in Phase 3 Studies
Dendreon Presents New Data Correlating Potency of PROVENGE to Survival in Phase 3 Studies
Additional items found! 56
Members Archive contains
56 additional stories matching:
Dendreon
(Password required)
Dendreon
(Password required)
